Stocktoria

ORASURE TECHNOLOGIES INC OSUR

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1986-11-17 · LEI

ORASURE TECHNOLOGIES INC financials (annual)

Revenue
$128.2M $167.1M $181.7M $154.6M $171.7M $233.7M $387.5M $405.5M $185.8M $115.0M 2016201720182019202020212022202320242025
Net income
$19.7M $30.9M $20.4M $16.7M -$14.9M -$23.0M -$17.1M $53.7M -$19.5M -$68.7M 2016201720182019202020212022202320242025
Free cash flow
$20.2M $23.8M $32.7M $490000 -$20.9M -$57.3M -$54.0M $135.8M $23.6M -$53.2M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$115.0M$185.8M$405.5M$387.5M$233.7M$171.7M$154.6M$181.7M$167.1M$128.2M
Gross profit$48.2M$79.4M$171.7M$148.4M$117.6M$101.9M$94.6M$113.6M$99.0M$88.0M
R&D expense$42.5M$26.0M$33.7M$36.2M$34.2M$31.0M$19.6M$16.2M$13.4M$9.8M
Operating income-$72.0M-$28.2M$32.7M-$22.2M-$10.2M-$5.2M$18.6M$28.4M$40.2M$20.3M
Income tax$1.8M$1.8M$2.6M$1.5M$13.7M$11.4M$4.7M$11.3M$10.1M$603,000
Net income-$68.7M-$19.5M$53.7M-$17.1M-$23.0M-$14.9M$16.7M$20.4M$30.9M$19.7M
EPS (diluted)$-0.94$-0.26$0.72$-0.24$-0.32$0.22$0.27$0.33$0.51$0.35
Operating cash flow-$49.0M$27.4M$141.6M-$47.2M-$35.4M$5.8M$9.8M$39.1M$28.2M$24.6M
Free cash flow-$53.2M$23.6M$135.8M-$54.0M-$57.3M-$20.9M$490,000$32.7M$23.8M$20.2M
Cash & equivalents$199.3M$267.8M$290.4M$84.0M$116.8M$160.8M$75.7M$88.4M$71.0M$108.0M
Inventory$31.1M$34.2M$47.6M$95.7M$53.1M$31.9M$23.2M$22.9M$19.3M$11.8M
Total assets$403.2M$479.7M$482.8M$444.2M$461.0M$454.5M$349.3M$315.6M$296.2M$207.9M
Total liabilities$62.3M$69.3M$52.2M$79.8M$80.5M$55.9M$42.1M$32.2M
Shareholders' equity$340.8M$410.3M$430.7M$364.4M$380.5M$398.6M$307.1M$283.4M$258.1M$185.8M

Growth · year-over-year · Revenue CAGR -1.2%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-38.1%-54.2%+4.6%+65.8%+36.1%+11.1%-14.9%+8.8%+30.3%+7.1%
Net income growth-136.3%-189.6%-18.3%-34.1%+56.9%+141.5%
EPS growth-136.1%-245.5%-18.5%-18.2%-35.3%+45.7%+150.0%
Free cash flow growth-325.7%-82.6%-4358.6%-98.5%+37.5%+17.7%+68.3%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.